Prostatic ductal adenocarcinoma is a rare neoplasm that develops from the prostatic urethra. We present an 85-year-old man with an exophytic lesion in the prostatic cavity, which was diagnosed after transurethral resection of the prostate. Histopathologically, the tumor was diagnosed as a ductal adenocarcinoma with endometrioid features and a Gleason score of 6. (Korean J Urol 2009;50:404-407)
Here we report on a patient who presented with gross hematuria and had a prostatic ductal adenocarcinoma.
CASE REPORT
An 85-year-old male with painful gross hematuria for 1 week came to the outpatient clinic of our institution. His medical and family history revealed no remarkable findings. A physical examination including a digital rectal examination (DRE) revealed an enlarged prostate gland and not palpable as firm, indurated nodules. An International Prostate Symptom Score of
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In the immunohistochemical examination, these cells showed focal prostate-specific antigen (PSA) positive immunoreactivity with anti-PSA antibody (x200). filled with eosinophilic debris that appears comedo-like. Invasion of prostatic tissue is noted in every specimen. 7 Immunohistochemistry of PSA and prostatic acid phosphatase can be very helpful in differentiating the prostatic origin of tumors in the prostatic and penile urethra. 8 In the present case, we found that the immunohistochemistry for PSA was focally positive. The treatment of choice for patients with any type of carcinoma of the prostatic ducts, with an early diagnosis, is radical prostatectomy followed by radiation. 6 Orihuela and Green 
